drugset / Trial / NCT01715324

Adjuvant Growth Therapy in in Vitro Fertilization

NCT01715324

Phase 4 Completed 288 enrolled Clinique Ovo EMD Serono · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

In an In Vitro Fertilization (IVF) cycle super ovulating drugs (gonadotropins) are usually taken to stimulate the ovaries to produce more than one egg. In Vitro Fertilization protocols are constantly under review in order to improve the recruitment of the follicles, which contain the eggs, whilst minimizing the doses of gonadotrophins required, with the ultimate aim of increasing the live birth rate.

Timeline

Start
2014-06-25
Primary completion
2021-07
Completion
2021-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 2.5 mg Subcutaneous

Indications